StockpollyBeta
Get App
Delisting riskPopularity #4,500
SBFM · NASDAQ · Drug Manufacturers - Specialty & Generic

Sunshine Biopharma (SBFM)

Commercializer of Canadian generic medicines with early-stage oncology and antiviral research.

$0.9229
vs last close+0.02 (+1.83%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue6889810999989
Cost of revenue455767666667
Gross profit232233333322
344445444534
Research & development010000000−100
233345443934
Selling & marketing000000000000
General & administrative233335343804
Other expenses000000000−400
Operating income−1−1−1−1−1−2−1−1−1−2−1−2
0000000−10000
Interest income000000000000
Interest expense000000000000
Other non-operating income000000010000
Income before tax−1−1−1−1−1−2−1−2−1−2−1−2
Income tax expense000000000000
Net income from continuing operations−1−1−10−1−2−1−2−1−2−1−2
Net income−1−1−10−1−2−1−2−1−2−1−2
EPS, basic−$507.20−$1,046.90−$400.40−$99.40−$9.40−$8.40−$4.40−$78.00−$1.90−$4.60−$2.50−$1.15
EPS, diluted−$507.20−$1,046.90−$400.40−$99.40−$9.40−$8.40−$4.40−$78.00−$1.90−$4.60−$2.50−$1.15
Weighted average shares, basic000000000001
Weighted average shares, diluted000000000001
EBITDA−1−1−1−1−1−2−1−2−1−2−1−2
Depreciation & amortization000000000000
EBIT−1−1−1−1−1−2−1−2−1−2−1−2